Search Results 321-330 of 24204 for In situ

1. A Study of Combination Chemotherapy for Treating Women with Stage II or Stage IIIA Breast Cancer that has Spread to the Lymph Nodes - Mayo Clinic

   ... in situ (less than 1 mm allowed). Concurrent enrollment on American College of Surgery Trial Z0010, Z0011, or NSABP B-32 allowed; Hormone receptor status.

2. A Study to Develop a Cohort Database and Study Platform in Breast Cancer Survivors Using Multiscale Omics - Mayo Clinic

   Have a prior diagnosis of stage 0-3 (in situ or invasive) breast cancer (BCS). Have completed active therapy (surgery, radiation, and/or chemotherapy) (8-30 ...

3. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

   ... in situ hybridization (FISH). Ductal carcinoma in situ (DCIS) components should not be counted in the determination of degree of IHC staining or FISH ...

4. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201) - Mayo Clinic

   non-melanoma skin cancer or carcinoma in situ within 2 years prior to enrollment 2. Prior systemic therapy, definitive therapy, radiation, or surgical ...

5. Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy - Mayo Clinic

   Prior history of in situ carcinoma is allowed. Patients with a prior history of any type of breast cancer greater than 5 years from study screening may ...

6. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Other active malignancy ≤5 years prior to registration. EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. NOTE: If there is a history ...

7. Tissue Repair and Regeneration: Mechanisms Underlying Cellular Senescence and Acute Skeletal Injury - Mayo Clinic Research

   ... in aging. Using gene expression and RNA in situ hybridization studies, we have shown that cells express p21 or p16Ink4a in unique populations of bone marrow ...

8. Breast cancer - Doctors and departments - Mayo Clinic

   ... situ, Lobular carcinoma in situ, Fibroadenoma, Atypical hyperplasia of ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida ...

9. Study assesses cost-effectiveness of pembrolizumab for treatment of bacillus Calmette-Guerin-unresponsive bladder carcinoma in situ - Mayo Clinic

   Salvage intravesical chemotherapy; Pembrolizumab in patients with carcinoma in situ with or without papillary tumor. Pembrolizumab received U.S. Food and Drug ...

10. Breast cancer - Doctors and departments - Mayo Clinic

    ... situ, Lobular carcinoma in situ, Fibroadenoma, Atypical hyperplasia of ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida ...